The present invention relates to novel compounds that are partial or full A1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including cardiovascular diseases, in particular arrhythmia, and the prevention of {HEAD ~ sudden death} resulting from arrhythmia, ischemia, CNS disorders including pain, {TAIL ~ epilepsy}, emesis, and metabolic disorders including diabetes and obesity 
The present invention relates to novel compounds that are partial or full A1 adenosine receptor agonists , and to their use in treating mammals for various disease states , including cardiovascular diseases , in particular arrhythmia , and the prevention of { HEAD ~ sudden death } resulting from arrhythmia , ischemia , CNS disorders including pain , { TAIL ~ epilepsy } , emesis , and metabolic disorders including diabetes and obesity
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH